Polymyalgia Rheumatica (PMR)

Rheumatology

Overview

Definition

An inflammatory rheumatic condition characterized by aching and morning stiffness in the shoulders, neck, and pelvic girdle.

Epidemiology

Almost exclusively affects individuals > 50 years old.

Etiology & Risk Factors

  • Unknown autoimmune trigger. Highly associated with Giant Cell Arteritis (Temporal Arteritis) - about 15-20% of patients with PMR will develop GCA.

Clinical Symptoms

  • Bilateral, severe aching and stiffness in the shoulders, neck, and hips/pelvis
  • Stiffness is worst in the morning (lasting > 45 minutes) and after periods of rest ('gel phenomenon')
  • Patients have difficulty getting out of a chair or lifting their arms above their head
  • NO objective muscle weakness (strength is normal, pain limits movement)

Clinical Approach

Diagnosis

  • Clinical diagnosis
  • Inflammatory markers: ESR and CRP are markedly elevated
  • Must explicitly ask about symptoms of Giant Cell Arteritis (headache, jaw claudication, visual changes)

Management

  • Low-dose Corticosteroids (e.g., Prednisone 15-20mg daily)
  • Response to steroids is typically RAPID and DRAMATIC (symptoms resolve within 24-48 hours; if they don't, question the diagnosis)
  • Usually requires a slow taper over 1-2 years

Complications

  • Significant impairment of daily activities if untreated
  • Development of Giant Cell Arteritis (which can cause irreversible blindness if missed)